HEADER APOPTOSIS 04-FEB-15 5AGW TITLE BCL-2 ALPHA BETA-1 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1, APOPTOSIS COMPND 3 REGULATOR BCL-2; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: RESIDUES 1-34,29-44,92-207; COMPND 6 SYNONYM: BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: CONTAINS RESIDUES 1-34,92-207 OF BCL-2 AND THE COMPND 9 UNSTRUCTURED LOOP BETWEEN RESIDUES 35-91 REPLACED IS WITH RESIDUES COMPND 10 35-50 OF BCL-XL; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: BCL-2-LIKE PROTEIN 11; COMPND 13 CHAIN: C, D; COMPND 14 FRAGMENT: RESIDUES 148-166; COMPND 15 SYNONYM: BCL2-L-11, BCL2-INTERACTING MEDIATOR OF CELL DEATH; COMPND 16 ENGINEERED: YES; COMPND 17 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-3; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-3 KEYWDS BCL-2, FOLDAMER, BIM, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR B.J.SMITH,E.F LEE,J.W.CHECCO,S.H.GELLMAN,W.D.FAIRLIE REVDAT 6 12-FEB-25 5AGW 1 REMARK REVDAT 5 01-MAY-24 5AGW 1 REMARK REVDAT 4 15-NOV-23 5AGW 1 LINK ATOM REVDAT 3 23-OCT-19 5AGW 1 SEQADV LINK REVDAT 2 23-SEP-15 5AGW 1 JRNL REVDAT 1 09-SEP-15 5AGW 0 JRNL AUTH J.W.CHECCO,E.F.LEE,M.EVANGELISTA,N.SLEEBS,K.RODGERS, JRNL AUTH 2 A.PETTIKIRIARACHCHI,N.KERSHAW,G.A.EDDINGER,D.G.BELAIR, JRNL AUTH 3 J.L.WILSON,C.H.ELLER,R.T.RAINES,W.L.MURPHY,B.J.SMITH, JRNL AUTH 4 S.H.GELLMAN,W.D.FAIRLIE JRNL TITL ALPHA BETA PEPTIDE FOLDAMERS TARGETING INTRACELLULAR JRNL TITL 2 PROTEIN-PROTEIN INTERACTIONS WITH ACTIVITY ON LIVING CELLS JRNL REF J.AM.CHEM.SOC. V. 137 11365 2015 JRNL REFN ISSN 0002-7863 JRNL PMID 26317395 JRNL DOI 10.1021/JACS.5B05896 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 12074 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.9713 - 4.2753 1.00 3020 159 0.1797 0.2450 REMARK 3 2 4.2753 - 3.3944 1.00 2863 150 0.1922 0.2693 REMARK 3 3 3.3944 - 2.9656 1.00 2824 149 0.2572 0.3261 REMARK 3 4 2.9656 - 2.6946 0.99 2764 145 0.3050 0.3864 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.500 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 79.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2634 REMARK 3 ANGLE : 1.274 3589 REMARK 3 CHIRALITY : 0.050 373 REMARK 3 PLANARITY : 0.005 456 REMARK 3 DIHEDRAL : 24.161 933 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 5.9760 11.0786 -18.7110 REMARK 3 T TENSOR REMARK 3 T11: 0.5839 T22: 0.5244 REMARK 3 T33: 0.4974 T12: 0.0399 REMARK 3 T13: -0.0175 T23: 0.1209 REMARK 3 L TENSOR REMARK 3 L11: 6.8231 L22: 2.8216 REMARK 3 L33: 3.8444 L12: -2.5406 REMARK 3 L13: -2.2251 L23: 0.8283 REMARK 3 S TENSOR REMARK 3 S11: -0.5842 S12: -0.6413 S13: -0.2248 REMARK 3 S21: 0.2147 S22: 0.2090 S23: -0.2223 REMARK 3 S31: 0.2106 S32: 0.5912 S33: 0.3604 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AGW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1290062950. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12081 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 33.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.2900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 9.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.080 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: UNPUBLISHED BCL-2 BECLIN BH3 COMPLEX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.02M CACL2, 0.1M MOPS PH7.0, 10% 2 REMARK 280 -PROPANOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.74000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.83650 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.83650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 80.61000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.83650 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.83650 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 26.87000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.83650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.83650 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 80.61000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.83650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.83650 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 26.87000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 53.74000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 ALA A 4 REMARK 465 GLY A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 ALA A 32 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 ASP A 76 REMARK 465 VAL A 77 REMARK 465 GLU A 78 REMARK 465 GLU A 79 REMARK 465 ASN A 80 REMARK 465 ARG A 81 REMARK 465 THR A 82 REMARK 465 GLU A 83 REMARK 465 ALA A 84 REMARK 465 PRO A 85 REMARK 465 GLU A 86 REMARK 465 GLY A 87 REMARK 465 THR A 88 REMARK 465 GLU A 89 REMARK 465 SER A 205 REMARK 465 MET A 206 REMARK 465 ARG A 207 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 HIS B 3 REMARK 465 ALA B 4 REMARK 465 GLY B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 GLY B 8 REMARK 465 TYR B 9 REMARK 465 ALA B 32 REMARK 465 GLY B 33 REMARK 465 ASP B 34 REMARK 465 ASP B 76 REMARK 465 VAL B 77 REMARK 465 GLU B 78 REMARK 465 GLU B 79 REMARK 465 ASN B 80 REMARK 465 ARG B 81 REMARK 465 THR B 82 REMARK 465 GLU B 83 REMARK 465 ALA B 84 REMARK 465 PRO B 85 REMARK 465 GLU B 86 REMARK 465 GLY B 87 REMARK 465 THR B 88 REMARK 465 GLU B 89 REMARK 465 SER B 205 REMARK 465 MET B 206 REMARK 465 ARG B 207 REMARK 465 ARG C 20 REMARK 465 ARG C 21 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 9 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 91 CG CD OE1 OE2 REMARK 470 LEU A 95 CG CD1 CD2 REMARK 470 ARG A 110 CG CD NE CZ NH1 NH2 REMARK 470 ALA A 113 CB REMARK 470 MET A 115 CG SD CE REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 GLU A 135 CG CD OE1 OE2 REMARK 470 ILE A 147 CD1 REMARK 470 GLU A 165 CG CD OE1 OE2 REMARK 470 ARG A 183 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 189 CD1 REMARK 470 LYS B 17 CG CD CE NZ REMARK 470 ASP B 31 CG OD1 OD2 REMARK 470 GLU B 91 CG CD OE1 OE2 REMARK 470 ARG B 109 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 110 CG CD NE CZ NH1 NH2 REMARK 470 ALA B 113 CB REMARK 470 GLN B 118 CG CD OE1 NE2 REMARK 470 ILE B 147 CD1 REMARK 470 ARG B 164 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 173 CD1 REMARK 470 GLU B 179 CG CD OE1 OE2 REMARK 470 ARG B 183 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 190 CG CD OE1 NE2 REMARK 470 ASP B 196 CG OD1 OD2 REMARK 470 GLU B 200 CG CD OE1 OE2 REMARK 470 LEU B 201 CG CD1 CD2 REMARK 470 TYR C 17 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG D 20 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 21 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2002 O HOH A 2002 8554 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 XCP C 2 CA - C - N ANGL. DEV. = -19.6 DEGREES REMARK 500 AJE D 6 C - N - CA ANGL. DEV. = -15.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 9 -111.94 71.27 REMARK 500 TYR A 108 45.71 -108.34 REMARK 500 GLN A 118 37.09 -85.53 REMARK 500 MET A 166 78.85 -159.28 REMARK 500 HIS A 184 -13.62 -158.60 REMARK 500 TYR A 202 -60.22 -90.60 REMARK 500 GLN B 25 28.09 -73.75 REMARK 500 VAL B 92 -59.26 -126.07 REMARK 500 HIS B 120 85.46 56.49 REMARK 500 HIS B 184 -25.71 -145.22 REMARK 500 ASP B 191 6.16 -61.54 REMARK 500 ASN B 192 21.87 -146.39 REMARK 500 TYR D 18 45.37 -94.71 REMARK 500 ARG D 20 -93.33 -142.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE C 1 XCP C 2 139.82 REMARK 500 AJE C 6 LEU C 7 147.37 REMARK 500 ASN C 15 XCP C 16 141.48 REMARK 500 ILE D 1 XCP D 2 132.47 REMARK 500 ASN D 15 XCP D 16 134.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 XCP C 2 17.36 REMARK 500 AJE C 6 -18.54 REMARK 500 XCP C 16 16.73 REMARK 500 XCP D 2 18.11 REMARK 500 AJE D 6 -19.88 REMARK 500 XCP D 16 16.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AGX RELATED DB: PDB REMARK 900 BCL-2 ALPHA BETA-1 LINEAR COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 CONTAINS RESIDUES 1-34, 92-207 OF BCL-2 AND THE REMARK 999 UNSTRUCTURED LOOP BETWEEN RESIDUES 35-91 REPLACED IS WITH REMARK 999 RESIDUES 35-50 OF BCL-XL REMARK 999 RESIDUES 2,6,16 ARE CYCLIC BETA AMINO ACIDS RESIDUES 9,13 REMARK 999 ARE PENETENYL S5 AMINO ACIDS THAT ARE CROSS-LINKED DBREF 5AGW A 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 5AGW A 76 91 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 5AGW A 92 207 UNP P10415 BCL2_HUMAN 92 207 DBREF 5AGW B 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 5AGW B 76 91 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 5AGW B 92 207 UNP P10415 BCL2_HUMAN 92 207 DBREF 5AGW C 1 21 UNP O43521 B2L11_HUMAN 146 166 DBREF 5AGW D 1 21 UNP O43521 B2L11_HUMAN 146 166 SEQADV 5AGW ACE C -1 UNP O43521 ACETYLATION SEQADV 5AGW ACE D -1 UNP O43521 ACETYLATION SEQADV 5AGW XCP C 2 UNP O43521 TRP 147 ENGINEERED MUTATION SEQADV 5AGW AJE C 6 UNP O43521 GLU 151 ENGINEERED MUTATION SEQADV 5AGW MH8 C 9 UNP O43521 ARG 154 ENGINEERED MUTATION SEQADV 5AGW MH8 C 13 UNP O43521 GLU 158 ENGINEERED MUTATION SEQADV 5AGW XCP C 16 UNP O43521 ALA 161 ENGINEERED MUTATION SEQADV 5AGW XCP D 2 UNP O43521 TRP 147 ENGINEERED MUTATION SEQADV 5AGW AJE D 6 UNP O43521 GLU 151 ENGINEERED MUTATION SEQADV 5AGW MH8 D 9 UNP O43521 ARG 154 ENGINEERED MUTATION SEQADV 5AGW MH8 D 13 UNP O43521 GLU 158 ENGINEERED MUTATION SEQADV 5AGW XCP D 16 UNP O43521 ALA 161 ENGINEERED MUTATION SEQRES 1 A 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 A 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 A 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 A 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 A 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 A 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 A 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 A 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 A 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 A 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 A 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 B 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 B 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 B 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 B 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 B 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 B 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 B 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 B 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 B 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 B 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 B 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 B 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 B 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 C 22 ACE ILE XCP ILE ALA GLN AJE LEU ARG MH8 ILE GLY ASP SEQRES 2 C 22 MH8 PHE ASN XCP TYR TYR ALA ARG ARG SEQRES 1 D 22 ACE ILE XCP ILE ALA GLN AJE LEU ARG MH8 ILE GLY ASP SEQRES 2 D 22 MH8 PHE ASN XCP TYR TYR ALA ARG ARG HET ACE C -1 3 HET XCP C 2 8 HET AJE C 6 15 HET MH8 C 9 9 HET MH8 C 13 9 HET XCP C 16 8 HET ACE D -1 3 HET XCP D 2 8 HET AJE D 6 15 HET MH8 D 9 9 HET MH8 D 13 9 HET XCP D 16 8 HETNAM ACE ACETYL GROUP HETNAM XCP (1S,2S)-2-AMINOCYCLOPENTANECARBOXYLIC ACID HETNAM AJE (3S,4R)-4-AMINO-1-(3-CARBOXYPROPANOYL)PYRROLIDINE-3- HETNAM 2 AJE CARBOXYLIC ACID HETNAM MH8 (2S)-2-AMINO-2-METHYLHEPT-6-ENOIC ACID FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 XCP 4(C6 H11 N O2) FORMUL 3 AJE 2(C9 H14 N2 O5) FORMUL 3 MH8 4(C8 H15 N O2) FORMUL 5 HOH *6(H2 O) HELIX 1 1 ASP A 10 ARG A 26 1 17 HELIX 2 2 GLU A 91 TYR A 108 1 18 HELIX 3 3 TYR A 108 GLN A 118 1 11 HELIX 4 4 THR A 125 PHE A 138 1 14 HELIX 5 5 ASN A 143 ARG A 164 1 22 HELIX 6 6 PRO A 168 LEU A 185 1 18 HELIX 7 7 LEU A 185 ASN A 192 1 8 HELIX 8 8 GLY A 194 GLY A 203 1 10 HELIX 9 9 ASP B 10 GLN B 25 1 16 HELIX 10 10 VAL B 92 TYR B 108 1 17 HELIX 11 11 TYR B 108 SER B 117 1 10 HELIX 12 12 THR B 122 PHE B 138 1 17 HELIX 13 13 ASN B 143 ARG B 164 1 22 HELIX 14 14 MET B 166 LEU B 185 1 20 HELIX 15 15 LEU B 185 ASP B 191 1 7 HELIX 16 16 GLY B 193 GLY B 203 1 11 LINK C ACE C -1 N ILE C 1 1555 1555 1.33 LINK C ILE C 1 N XCP C 2 1555 1555 1.33 LINK C XCP C 2 N ILE C 3 1555 1555 1.32 LINK C GLN C 5 N AJE C 6 1555 1555 1.34 LINK C AJE C 6 N LEU C 7 1555 1555 1.33 LINK C ARG C 8 N MH8 C 9 1555 1555 1.33 LINK C MH8 C 9 N ILE C 10 1555 1555 1.33 LINK CE MH8 C 9 CE MH8 C 13 1555 1555 1.34 LINK C ASP C 12 N MH8 C 13 1555 1555 1.33 LINK C MH8 C 13 N PHE C 14 1555 1555 1.33 LINK C ASN C 15 N XCP C 16 1555 1555 1.33 LINK C XCP C 16 N TYR C 17 1555 1555 1.33 LINK C ACE D -1 N ILE D 1 1555 1555 1.34 LINK C ILE D 1 N XCP D 2 1555 1555 1.33 LINK C XCP D 2 N ILE D 3 1555 1555 1.33 LINK C GLN D 5 N AJE D 6 1555 1555 1.33 LINK C AJE D 6 N LEU D 7 1555 1555 1.34 LINK C ARG D 8 N MH8 D 9 1555 1555 1.33 LINK C MH8 D 9 N ILE D 10 1555 1555 1.32 LINK CE MH8 D 9 CE MH8 D 13 1555 1555 1.41 LINK C ASP D 12 N MH8 D 13 1555 1555 1.33 LINK C MH8 D 13 N PHE D 14 1555 1555 1.32 LINK C ASN D 15 N XCP D 16 1555 1555 1.33 LINK C XCP D 16 N TYR D 17 1555 1555 1.33 CISPEP 1 GLY A 203 PRO A 204 0 3.90 CRYST1 87.673 87.673 107.480 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011406 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011406 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009304 0.00000